Literature DB >> 10599531

Development of recombinant varicella-zoster virus vaccines.

A M Arvin1, S Mallory, J F Moffat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10599531     DOI： 10.1159/000060324

Source DB:  PubMed          Journal:  Contrib Microbiol        ISSN： 1420-9519


× No keyword cloud information.
  4 in total

1.  Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques.

Authors:  V Traina-Dorge; B Pahar; P Marx; P Kissinger; D Montefiori; Y Ou; W L Gray
Journal:  Vaccine       Date:  2010-07-21       Impact factor: 3.641

2.  Recombinant simian varicella viruses induce immune responses to simian immunodeficiency virus (SIV) antigens in immunized vervet monkeys.

Authors:  Yang Ou; Vicki Traina-Dorge; Kara A Davis; Wayne L Gray
Journal:  Virology       Date:  2007-04-16       Impact factor: 3.616

3.  Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic.

Authors:  Toby M Ward; Vicki Traina-Dorge; Kara A Davis; Wayne L Gray
Journal:  J Gen Virol       Date:  2008-03       Impact factor: 3.891

4.  Increased cellular immune responses and CD4+ T-cell proliferation correlate with reduced plasma viral load in SIV challenged recombinant simian varicella virus - simian immunodeficiency virus (rSVV-SIV) vaccinated rhesus macaques.

Authors:  Bapi Pahar; Wayne L Gray; Kimberly Phelps; Elizabeth S Didier; Eileen deHaro; Preston A Marx; Vicki L Traina-Dorge
Journal:  Virol J       Date:  2012-08-13       Impact factor: 4.099
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.